Cargando…
Effectiveness and safety of repeat dexamethasone for bronchopulmonary dysplasia
OBJECTIVE: To describe effectiveness of repeat dexamethasone for bronchopulmonary dysplasia (BPD) and to evaluate adverse effects on growth. STUDY DESIGN: Retrospective study of infants treated with 1 or 2 courses of dexamethasone for BPD. Effectiveness was defined as successful step-down in respira...
Autores principales: | Cuna, Alain, Quiqley, Anastasia, Varghese, Kevin, Ciccolari-Micaldi, Greta, Oliveros, Christian, Cheng, An-Lin, Norberg, Michael, Truog, William E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184867/ https://www.ncbi.nlm.nih.gov/pubmed/34103670 http://dx.doi.org/10.1038/s41372-021-01125-3 |
Ejemplares similares
-
Pharmacometabolomics of Respiratory Phenotypic Response to Dexamethasone in Preterm Infants at Risk for Bronchopulmonary Dysplasia
por: Lewis, Tamorah, et al.
Publicado: (2019) -
Pharmacometabolomics Profiling of Preterm Infants Validates Patterns of Metabolism Associated With Response to Dexamethasone Treatment for Bronchopulmonary Dysplasia
por: Stockard, Bradley, et al.
Publicado: (2022) -
Genetic Variation in CRHR1 is Associated with
Short-Term Respiratory Response to Corticosteroids in Preterm Infants at risk
for Bronchopulmonary Dysplasia
por: Lewis, Tamorah, et al.
Publicado: (2018) -
Impact of tracheostomy on language and cognitive development in infants with severe bronchopulmonary dysplasia
por: Cammack, Betsy, et al.
Publicado: (2019) -
Impact of intercurrent respiratory infections on lung health in infants born <29 weeks with bronchopulmonary dysplasia
por: Taylor, J B, et al.
Publicado: (2013)